Norges Bank’s Gossamer Bio GOSS Stock Holding History

Norges Bank’s Portfolio GOSS Stock Details GOSS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-309,300	Closed	-$2.59M	–	2104
2022 Q2	$2.59M	Sell	309,300 -415,500	-57%	-$3.22M	﹤0.01%	1864
2022 Q1	$6.29M	Hold	724,800	–	–	﹤0.01%	1824
2021 Q4	$8.2M	Hold	724,800	–	–	﹤0.01%	1815
2021 Q3	$9.11M	Hold	724,800	–	–	﹤0.01%	1798
2021 Q2	$5.88M	Hold	724,800	–	–	﹤0.01%	1879
2021 Q1	$6.7M	Sell	724,800 -181,200	-20%	-$1.83M	﹤0.01%	1866
2020 Q4	$8.76M	Hold	906,000	–	–	﹤0.01%	1790
2020 Q3	$11.2M	Hold	906,000	–	–	﹤0.01%	1678
2020 Q2	$11.8M	Buy	906,000 +436,000	+93%	+$5.48M	﹤0.01%	1670
2020 Q1	$4.77M	Sell	470,000 -324,275	-41%	-$4.23M	﹤0.01%	1834
2019 Q4	$12.4M	Buy	794,275 +51,284	+7%	+$1.03M	﹤0.01%	1742
2019 Q3	$12.5M	Buy	742,991 +85,910	+13%	+$1.71M	﹤0.01%	1702
2019 Q2	$14.6M	Buy	657,081 +187,081	+40%	+$3.58M	﹤0.01%	1656
2019 Q1	$10.2M	Buy	+470,000	New	+$9.8M	﹤0.01%	1795

Other funds holding GOSS

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

WAM

Weiss Asset Management Boston, Massachusetts $5.91B AUM 42.42% 1-Year Est. Return

Norges Bank's GOSS Position: Q3 2022 in Review

Norges Bank sold out of Gossamer Bio (GOSS) in Q3 2022, closing a stake of 309,300 shares — an estimated $2.59M sold.

Norges Bank first reported a position in GOSS in Q1 2019 and held it in 14 quarters. The position peaked at $14.6M in Q2 2019. 160 funds tracked by Wall St. Rank hold GOSS as of Q3 2022.

Norges Bank reported no remaining Gossamer Bio position as of Q3 2022 after selling out during the quarter.
Norges Bank sold 309,300 Gossamer Bio shares in Q3 2022, an estimated $2.59M.
Norges Bank first reported a position in Gossamer Bio in Q1 2019 and held it in 14 quarters.
Norges Bank's Gossamer Bio position peaked at $14.6M in Q2 2019.
160 funds tracked by Wall St. Rank held Gossamer Bio as of Q3 2022.

Based on Norges Bank's 13F filing for Q3 2022, filed 14 Nov 2022.